Transforming Opioid Overdose Prevention in the United States: Leveraging FDA's Narcan Approval to Foster a Culture of Health
- PMID: 40535536
- PMCID: PMC12176100
- DOI: 10.2147/RMHP.S521720
Transforming Opioid Overdose Prevention in the United States: Leveraging FDA's Narcan Approval to Foster a Culture of Health
Abstract
The opioid crisis in the United States remains a major public health emergency, claiming over 100,000 lives annually, with potent synthetic opioids like fentanyl driving the surge in overdose deaths. In response, the US Food and Drug Administration's (FDA) approval of over-the-counter (OTC) Narcan represents a pivotal step toward expanding access to naloxone, a life-saving medication that reverses opioid overdoses. However, maximizing the public health impact of this measure requires more than increasing availability-it demands a comprehensive, systemic approach that fosters community engagement, advances harm reduction, and transforms healthcare delivery. This paper applies the Robert Wood Johnson Foundation's (RWJF) Culture of Health (COH) model to provide a structured framework for optimizing Narcan's impact. Through its four interconnected pillars, (1) making health a shared value, (2) fostering cross-sector collaboration, (3) ensuring equitable access, and (4) transforming healthcare systems, the COH model offers critical insights into building sustainable, community-wide overdose prevention strategies. Central to this effort is stigma reduction, as negative perceptions of opioid use disorder continue to undermine both public willingness to seek naloxone and healthcare providers' readiness to offer it. Within the COH framework, the paper examines evidence-based interventions that normalize naloxone use, innovative cross-sector partnerships that foster acceptance, and policy initiatives that expand access while addressing systemic inequities. By synthesizing real-world success stories, including community-based naloxone distribution programs, law enforcement-assisted interventions, and hospital-based harm reduction initiatives, this paper outlines a strategic blueprint for translating the FDA's Narcan ruling into lasting public health outcomes. It concludes with actionable recommendations for healthcare systems, policymakers, and public health agencies to institutionalize harm reduction practices and dismantle barriers to care. Only by embedding a Culture of Health into the fabric of healthcare, public health, and community systems can we achieve lasting progress against the opioid crisis and foster healthier, more equitable communities.
Keywords: Narcan; culture of health model; harm reduction; health equity; naloxone access; opioid crisis; overdose prevention; substance use disorder.
© 2025 Rangachari and Tran.
Conflict of interest statement
The authors report no conflicts of interest in this work.
References
-
- National Institute on Drug Abuse. (2023). Drug Overdose Death Rates. Available from: https://nida.nih.gov/research-topics/trends-statistics/overdose-death-rates. Accessed June 11, 2025.
-
- National Institute on Drug Abuse. (2021). Naloxone Drug Facts. Available from: https://nida.nih.gov/publications/drugfacts/naloxone. Accessed June 11, 2025.
-
- U.S. Department of Health and Human Services. Overdose Prevention Strategy. Available from: https://www.hhs.gov/overdose-prevention/. Accessed June 11, 2025.
-
- Centers for Disease Control and Prevention. (2022). U.S. Overdose Deaths In 2021 Increased Half as Much as in 2020. Available from: https://www.cdc.gov/nchs/pressroom/nchs_press_releases/2022/202205.htm. Accessed June 11, 2025.
-
- U.S. Food and Drug Administration. (2023, March 29,). FDA Approves First Over-the-Counter Naloxone Nasal Spray. Available from: https://www.fda.gov/news-events/press-announcements/fda-approves-first-o.... Accessed June 11, 2025.
LinkOut - more resources
Full Text Sources
